We studied autistics by quantitative EEG spectral and coherence analysis during three experimental conditions: basal, watching a cartoon with audio (V–A), and with muted audio band (VwA). Significant reductions were found for the absolute power spectral density (PSD) in the central region for delta and theta, and in the posterior region for sigma and beta bands, lateralized to the right hemisphere. When comparing VwA versus the V–A in the midline regions, we found significant decrements of absolute PSD for delta, theta and alpha, and increments for the beta and gamma bands. In autistics, VwA versus V–A tended to show lower coherence values in the right hemisphere. An impairment of visual and auditory sensory integration in autistics might explain our results.
Several reports have been published over recent years about the paradoxical "arousing" effect of Zolpidem, a highly selective nonbenzodiazepine gamma aminobutyric acid (GABA) agonist acting on the [omega]-1 site of the GABA A receptor, in persistent vegetative state (PVS), in minimally conscious state (MCS) patients, ischemic stroke cases, after brain injury, and in patients suffering hypoxic encephalopathy. 1We describe here this paradoxical arousing effect in a PVS case assessing autonomic, electroencephalographic (EEG), and behavioral changes, after Zolpidem uptake. This case report is the first to show the importance of using heart rate variability (HRV) methodology and EEG to assess autonomic and brain functional changes in a PVS case, during this pharmacological intervention. METHODSWe studied a 21-year-old female patient (YOR), who had suffered a stroke causing a top of the basilar artery syndrome and who had been in PVS for five years. Magnetic resonance imaging showed destruction of the rostral part of the pons, the mesencephalon, and both thalami. The patient showed circadian wakefulness, although she maintained longer periods of time with her eyes closed. With informed written consent of her parents, 10 mg of Zolpidem were administered through a percutaneous endoscopic gastrostomy. A control healthy subject (DMC) matched for age and gender, without any history of autonomic or any other nervous system disorder, non-smoker, and who was not under any medication was also included. Zolpidem 10 mg dissolved in 30 ml saline solution was administered orally to subject DMC. This pharmacologic intervention was approved by the Institute of Neurology and Neurosurgery Ethics Committee, Havana, Cuba. Electroencephalographic studiesElectroencephalographic records were obtained by the digital MEDICID-05 system (Neuronic S.A.), with the following technical parameters: gain 20,000, filters pass-band 0.1-30 Hz, 60 Hz "notch" filter, level of noise 2μv root mean square, sampling period of 5 ms, and environmental temperature of approximately 23°C. Nineteen monopolar leads were placed according to the International 10/20 System, using EEG AgAgCl scalp electrodes, with linked ear lobes as a reference. Electrode-skin impedance was lower than 10 KΩ. The six EEG spectra obtained before and after every observed yawn were averaged to obtain the pre and postyawning averaged spectra. Usual spectral indices were also calculated. Autonomic studiesElectrocardiogram was simultaneously digitally recorded with EEG and was exported offline to a custom-tailored software tool developed by our staff for visual inspection and detection of the "R" wave peaks. Accurate "R" peak detections were visually controlled and properly corrected when it was necessary. The whole consecutive 80 minutes sequence of R-R intervals was submitted to a piecewise cubic Hermite interpolation process with a sampling frequency of approx-imately 6.83 Hz, to transform the ordinal R-R sequence into a proper time series. Later, a dynamic time-frequency spectral analysi...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.